About
Generics
Areas of Focus
Categories
Generic Drug
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
4
As Collaborator
4
Total Enrollment
45,459
By Phase
PHASE2/PHASE3: 1PHASE2: 1PHASE1: 1NA: 2PHASE3: 1PHASE4: 1
By Status
COMPLETED: 5RECRUITING: 1ACTIVE_NOT_RECRUITING: 1SUSPENDED: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06978842Lead Sponsor
Seizure Prediction Using Wearable EEG
N/ARecruiting
150 participants
Started: Jun 19, 2025 · Completed: Mar 31, 2026
NCT06146101Lead Sponsor
RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA
PHASE2/PHASE3Active, not recruiting
560 participants
Started: May 2, 2024 · Completed: Dec 31, 2026
NCT05942911Lead Sponsor
Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis
PHASE2Suspended
20 participants
Started: Nov 22, 2023 · Completed: Oct 28, 2025
NCT05857384Lead Sponsor
Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs
PHASE1Completed
125 participants
Started: Sep 8, 2023 · Completed: Jul 31, 2024
NCT04732806Collaborator
A Mightier Healthcare System
NACompleted
183 participants
Started: Mar 10, 2021 · Completed: Oct 1, 2025
Locations (1)
Headquarters
Warwick, UK
Map
Loading map...